Ezra Gabbay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ezra Gabbay has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Klemens B. Meyer
William B. Schwartz Division of Nephrology and † Institute for Clinical and Health Policy Research, Clinical and Translational Science Institute Tufts Medical Center Boston Massachusetts
2 shared publicationsDana C. Miskulin
William B. Schwartz Division of Nephrology and † Institute for Clinical and Health Policy Research, Clinical and Translational Science Institute Tufts Medical Center Boston Massachusetts
1 shared publicationJohn L. Griffith
Division of Nephrology, Tufts Medical Center 800 Washington Street 02111. Boston MA
1 shared publicationMichelle M. Richardson
William B. Schwartz Division of Nephrology and † Institute for Clinical and Health Policy Research, Clinical and Translational Science Institute Tufts Medical Center Boston Massachusetts
1 shared publication
Latest Publications
- Open Access
- 1 February 2010
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (2) , 261-267
Temporal Trends in Health-Related Quality of Life among Hemodialysis Patients in the United States
Background and objectives: Health-related quality of life (HRQOL) is a measure of the well being of hemodialysis patients and an independent prognostic predictor. Our aim was to determine whether HRQOL among hemodialysis patients has changed over time. Design, setting, participants, & measurements: We retrospectively analyzed data collected by Dialysis Clinic, Inc. from adult patients starting hemodialysis between January 1, 1997 and May 31, 2006. The primary outcome was HRQOL assessed by Short Form 36, 6 to 18 months after and closest to the 1-year anniversary of starting hemodialysis. Secular trends were analyzed by linear regression for continuous variables and logistic regression for categorical ones. Year of starting dialysis was the predictor. A five-point difference on a 0 to 100 scale was considered clinically significant. Results: Short Form 36 scores were available for 11,079 patients. Role Physical, General Health, Vitality, Social Functioning, and Physical Component Summary scores were unchanged among patients over the study period. Statistically significant (P < 0.05) but clinically insignificant changes were observed in Physical Functioning (−0.2 points/yr), Bodily Pain (+0.2 points/yr), Mental Health (+0.15 points/yr), and Mental Component Summary scores (+0.13 points/yr). Only Role Emotional showed clinically significant improvement. Trends were unchanged after adjusting for age, gender, race, diabetes, hemoglobin, phosphorous, Kt/V, and albumin. Conclusions: Most HRQOL domains showed either no statistically significant change or statistically but not clinically significant change over almost a decade. These results suggest that, despite important developments in hemodialysis care since 1997, little progress was made in improving HRQOL of hemodialysis patients.
- 1 February 2010
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (2) , 261-267
Open AccessTemporal Trends in Health-Related Quality of Life among Hemodialysis Patients in the United States
Background and objectives: Health-related quality of life (HRQOL) is a measure of the well being of hemodialysis patients and an independent prognostic predictor. Our aim was to determine whether HRQOL among hemodialysis patients has changed over time. Design, setting, participants, & measurements: We retrospectively analyzed data collected by Dialysis Clinic, Inc. from adult patients starting hemodialysis between January 1, 1997 and May 31, 2006. The primary outcome was HRQOL assessed by Short Form 36, 6 to 18 months after and closest to the 1-year anniversary of starting hemodialysis. Secular trends were analyzed by linear regression for continuous variables and logistic regression for categorical ones. Year of starting dialysis was the predictor. A five-point difference on a 0 to 100 scale was considered clinically significant. Results: Short Form 36 scores were available for 11,079 patients. Role Physical, General Health, Vitality, Social Functioning, and Physical Component Summary scores were unchanged among patients over the study period. Statistically significant (P < 0.05) but clinically insignificant changes were observed in Physical Functioning (−0.2 points/yr), Bodily Pain (+0.2 points/yr), Mental Health (+0.15 points/yr), and Mental Component Summary scores (+0.13 points/yr). Only Role Emotional showed clinically significant improvement. Trends were unchanged after adjusting for age, gender, race, diabetes, hemoglobin, phosphorous, Kt/V, and albumin. Conclusions: Most HRQOL domains showed either no statistically significant change or statistically but not clinically significant change over almost a decade. These results suggest that, despite important developments in hemodialysis care since 1997, little progress was made in improving HRQOL of hemodialysis patients.
- Open Access
- 22 December 2008
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 2 (2) , 97-103
Identifying critically ill patients with acute kidney injury for whom renal replacement therapy is inappropriate: an exercise in futility?
Clinicians treating critically ill patients must consider the possibility that painful and expensive aggressive treatments might confer negligible benefit. Such treatments are often described as futile or inappropriate. We discuss the problem of deciding whether to initiate renal replacement therapy (RRT) for critically ill patients with acute kidney injury (AKI) in the context of the debate surrounding medical futility. The main problems in deciding when such treatment would be futile are that the concept itself is controversial and eludes quantitative definition, that available outcome data do not allow confident identification of patients who will not benefit from treatment and that the decision on RRT in a critically ill patient with AKI is qualitatively different from decisions on other modalities of intensive care and resuscitation, as well as from decisions on dialysis for chronic kidney disease. Despite these difficulties, nephrologists need to identify circumstances in which continued aggressive care would be futile before proceeding to initiate RRT.
- 22 December 2008
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 2 (2) , 97-103
Open AccessIdentifying critically ill patients with acute kidney injury for whom renal replacement therapy is inappropriate: an exercise in futility?
Clinicians treating critically ill patients must consider the possibility that painful and expensive aggressive treatments might confer negligible benefit. Such treatments are often described as futile or inappropriate. We discuss the problem of deciding whether to initiate renal replacement therapy (RRT) for critically ill patients with acute kidney injury (AKI) in the context of the debate surrounding medical futility. The main problems in deciding when such treatment would be futile are that the concept itself is controversial and eludes quantitative definition, that available outcome data do not allow confident identification of patients who will not benefit from treatment and that the decision on RRT in a critically ill patient with AKI is qualitatively different from decisions on other modalities of intensive care and resuscitation, as well as from decisions on dialysis for chronic kidney disease. Despite these difficulties, nephrologists need to identify circumstances in which continued aggressive care would be futile before proceeding to initiate RRT.